Skip to main content

Table 1 Effects of NH replacement and DNP administration on lifetime expectancy and QALY

From: Lifetime expectancy and quality-adjusted life-year in Alzheimer’s disease with and without cerebrovascular disease: effects of nursing home replacement and donepezil administration – a retrospective analysis in the Tajiri Project

 

own homes

NH replacement

F-values

covariance

 

no DNP

DNP

no DNP

DNP

NH

DNP

interact

age

sex

AD

n = 25

n = 27

n = 6

n = 7

     

lifetime expectancy

56.3 (44.6)

84.7 (36.3)

122.5 (59.7)

156.4 (37.8)

20.442***

4.704*

0.002

0.873

2.482

QALY

26.4 (17.8)

47.0 (20.5)

53.1 (18.2)

75.7 (18.5)

15.123***

11.859***

0.000

0.854

3.738

AD with CVD

n = 9

n = 14

n = 8

n = 4

     

lifetime expectancy

49.9 (41.6)

77.6 (32.9)

57.5 (44.6)

119.0 (46.2)

2.207

7.861**

1.034

0.265

0.364

QALY

30.4 (21.3)

41.9 (16.1)

30.8 (27.1)

54.4 (29.4)

0.74

3.608

0.65

0.077

2.162

  1. Two-way ANOVAs with the covariance of age and gender were performed
  2. *p < 0.05, **p < 0.01, ***p < 0.001
  3. AD Alzheimer's disease, CVD cerebrovascular diseases, QALY quality-adusted life-year
  4. DNP donepezil, NH nursing home